loader
Please Wait
Applying Filters...
Close
4

Evonik Evonik

X

List of Drug Master Files (DMF) of Irinotecan Hydrochloride Trihydrate Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Fermion Oy (1)

02 Sun Pharmaceutical Industries Limited (3)

03 Mac-Chem Products (India) Pvt.Ltd (1)

04 ALP Pharm (1)

05 Arch Pharmalabs (1)

06 Benzo Chem Industries Pvt. Ltd. (1)

07 Charioteer (1)

08 Cipla (1)

09 Emcure Pharmaceuticals (1)

10 Fresenius Kabi AB Brunna (1)

11 Hetero Drugs (1)

12 Hubei Haosun Pharmaceutical Co., Ltd. (1)

13 JARI Pharmaceutical Co., Ltd. (1)

14 Jiangsu Hengrui Medicine (1)

15 Laurus Labs (1)

16 Olon S.p.A (1)

17 Pliva Hrvatska (1)

18 Polymed Therapeutics Inc. (2)

19 Qilu Pharmaceutical (1)

20 Sai Phytoceuticals (1)

21 ScinoPharm Taiwan, Ltd (2)

22 Shilpa Medicare (1)

23 Sichuan Xieli Pharmaceutical (1)

24 Terumo (1)

25 YAKULT HONSHA CO LTD (2)

26 Zhejiang Hisun Pharmaceutical (1)

27 Zydus Lifesciences (1)

filter

01 CPT-11 (1)

02 IHL- 305 IRINOTECAN LIPOSOME INJECTION (1)

03 IRINOTECAN HCL (1)

04 IRINOTECAN HYDROCHLORIDE (5)

05 IRINOTECAN HYDROCHLORIDE (NON STERILE, API) (1)

06 IRINOTECAN HYDROCHLORIDE TRIHYDRATE (8)

07 IRINOTECAN HYDROCHLORIDE TRIHYDRATE (NON-STERILE BULK) DRUG SUBSTANCE (1)

08 IRINOTECAN HYDROCHLORIDE TRIHYDRATE USP (5)

09 IRINOTECAN HYDROCHLORIDE TRIHYDRATE, USP (FORM B) (1)

10 IRINOTECAN HYDROCHLORIDE USP (4)

11 IRINOTECAN HYDROCHLORIDE USP (NON-STERILE BULK) DRUG SUBSTANCE (1)

12 IRINOTICAN HYDROCHLORIDE (1)

13 SN38 (1)

14 TOTAL SYNTHESIS OF TSN-38B-11 INTERMEDIATE COMPOUND USED IN THE MANUFACTURE OF IRINOTECAN HYDROCHLORIDE TRIHYRATE (CPT-11) DRUG SUBSTANCE (1)

filter

01 China (8)

02 Croatia (1)

03 Finland (1)

04 India (13)

05 Italy (1)

06 Japan (3)

07 Sweden (1)

08 Taiwan (2)

09 U.S.A (2)

filter

01 Active (18)

02 Inactive (14)

filter

01 Complete (8)

02 Blank (24)

20649
Active
2007-06-29
Complete
2013-09-14
2013-09-05
II
URL Supplier Web Content
32675
Active
2018-03-29
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
30261
Active
2016-08-05
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
20195
Inactive
2007-01-12
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
26554
Active
2012-09-14
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
17456
Active
2004-06-08
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
20739
Active
2007-08-01
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
19050
Active
2005-12-20
Complete
2012-11-23
2012-11-09
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
17312
Active
2004-04-20
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
21183
Active
2007-12-25
N/A
II
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 100286-90-6 / Irinotecan Hydrochloride API manufacturers, exporters & distributors?

Irinotecan Hydrochloride manufacturers, exporters & distributors 1

58

PharmaCompass offers a list of Irinotecan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier.

PharmaCompass also assists you with knowing the Irinotecan Hydrochloride API Price utilized in the formulation of products. Irinotecan Hydrochloride API Price is not always fixed or binding as the Irinotecan Hydrochloride Price is obtained through a variety of data sources. The Irinotecan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Irinotecan Hydrochloride

Synonyms

100286-90-6, Irinotecan hcl, Topotecin, Campto, Camptothecin 11 hydrochloride, Camptosar

Cas Number

100286-90-6

Unique Ingredient Identifier (UNII)

06X131E4OE

About Irinotecan Hydrochloride

A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.

Irinotecan Hydrochloride Trihydrate Manufacturers

A Irinotecan Hydrochloride Trihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Irinotecan Hydrochloride Trihydrate, including repackagers and relabelers. The FDA regulates Irinotecan Hydrochloride Trihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Irinotecan Hydrochloride Trihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Irinotecan Hydrochloride Trihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Irinotecan Hydrochloride Trihydrate Suppliers

A Irinotecan Hydrochloride Trihydrate supplier is an individual or a company that provides Irinotecan Hydrochloride Trihydrate active pharmaceutical ingredient (API) or Irinotecan Hydrochloride Trihydrate finished formulations upon request. The Irinotecan Hydrochloride Trihydrate suppliers may include Irinotecan Hydrochloride Trihydrate API manufacturers, exporters, distributors and traders.

click here to find a list of Irinotecan Hydrochloride Trihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Irinotecan Hydrochloride Trihydrate USDMF

A Irinotecan Hydrochloride Trihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Irinotecan Hydrochloride Trihydrate active pharmaceutical ingredient (API) in detail. Different forms of Irinotecan Hydrochloride Trihydrate DMFs exist exist since differing nations have different regulations, such as Irinotecan Hydrochloride Trihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Irinotecan Hydrochloride Trihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Irinotecan Hydrochloride Trihydrate USDMF includes data on Irinotecan Hydrochloride Trihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Irinotecan Hydrochloride Trihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Irinotecan Hydrochloride Trihydrate suppliers with USDMF on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY